Assenagon Asset Management S.A. Corcept Therapeutics Inc Transaction History

Assenagon Asset Management S.A.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 01, 2021	SELL	$16.78 - $27.3 $5.87 Million - $9.55 Million	-349,667 Closed	0 $0
Q3 2020 Oct 07, 2020	BUY	$12.46 - $19.98 $4.36 Million - $6.99 Million	349,667 New	349,667 $6.09 Million
Q2 2020 Jul 21, 2020	SELL	$11.0 - $18.26 $1.64 Million - $2.71 Million	-148,685 Closed	0 $0
Q1 2020 Apr 17, 2020	BUY	$10.11 - $14.04 $1.5 Million - $2.09 Million	148,685 New	148,685 $1.77 Million

347

86.6M

1.12M

667K

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $6.3B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

Get notified when there are updates to the investment portfolio of Assenagon Asset Management S.A., based on Form 13F filings with the SEC.

Stay updated on Assenagon Asset Management S.A. with notifications on news.